Creative Medical Technology Holdings, Inc. (CELZ) income statement
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.40−0.04 (-8.52%)
Close on Nov 20, 2026Market cap $2.65MP/E –Yield –
Creative Medical Technology Holdings, Inc. financial ratios
See a number that looks wrong?